Determination of nelfinavir free drug concentrations in plasma by equilibrium dialysis and liquid chromatography/tandem mass spectrometry: important factors for method optimization

This publication has 13 references indexed in Scilit:

• An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma
  Journal of Pharmaceutical and Biomedical Analysis, 2001
• Determination of unbound drug concentration and protein-drug binding fraction in plasma
  Biomedical Chromatography, 1999
• Nelfinavir Mesylate: A Protease Inhibitor
  Annals of Pharmacotherapy, 1999
• Failure to Detect Nelfinavir in the Cerebrospinal Fluid of HIV-1-Infected Patients With and Without AIDS Dementia Complex
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• HIV-Protease Inhibitors
  New England Journal of Medicine, 1998
• Drug-protein binding studies new trends in analytical and experimental methodology
  Journal of Chromatography B: Biomedical Sciences and Applications, 1996
• Comparative Evaluation of Microultrafiltration Devices for Determination of Protein Binding
  Therapeutic Drug Monitoring, 1988
• Rationale for Monitoring Free Drug Levels
  Clinical Pharmacokinetics, 1984
• Serum protein pattern in normal pregnancy with special reference to acute‐phase reactants
  BJOG: An International Journal of Obstetrics and Gynaecology, 1983
• Importance of Protein Binding for the Interpretation of Serum or Plasma Drug Concentrations
  The Journal of Clinical Pharmacology, 1982